Polycystic ovary syndrome
Effects of protein versus simple sugar intake on weight loss in polycystic ovary syndrome (according to the National Institutes of Health criteria)

https://doi.org/10.1016/j.fertnstert.2008.05.065Get rights and content
Under an Elsevier user license
open archive

Objective

To compare the effects of protein vs. simple sugars on weight loss, body composition, and metabolic and endocrine parameters in polycystic ovary syndrome (PCOS).

Design

A 2-month, free-living, randomized, single-blinded study.

Setting

University PCOS clinic.

Patient(s)

Thirty-three patients with PCOS.

Intervention(s)

To achieve a final energy reduction of 450 kcal/day, first the daily energy intake was reduced by 700 kcal; then a 240-kcal supplement containing either whey protein or simple sugars was added.

Main Outcome Measure(s)

Changes in weight, fat mass, fasting glucose and insulin, plasma lipoproteins, and sex steroids.

Result(s)

Twenty-four subjects (13 in the simple sugars group and 11 in the protein group) completed the study. The protein group lost more weight (−3.3 ± 0.8 kg vs. −1.1 ± 0.6 kg) and more fat mass (−3.1 ± 0.9 kg vs. −0.5 ± 0.6 kg) and had larger decreases in serum cholesterol (−33.0 ± 8.4 mg/dL vs. −2.3 ± 6.8 mg/dL), high-density lipoprotein cholesterol (−4.5 ± 1.3 mg/dL vs. −0.4 ± 1.3 mg/dL), and apoprotein B (−20 ± 5 mg/dL vs. 3 ± 5 mg/dL).

Conclusion(s)

In patients with PCOS, a hypocaloric diet supplemented with protein reduced body weight, fat mass, serum cholesterol, and apoprotein B more than the diet supplemented with simple sugars.

Key Words

PCOS
weight loss
whey protein

Cited by (0)

S.E.K.-K. has nothing to disclose. R.U.A. has nothing to disclose. W.C. has nothing to disclose.

Supported by grants from the California Dairy Research Foundation and the ALSAM Foundation (S.E.K.-K.). The whey protein and carbohydrate supplements were provided by Glanbia Foods, Twin Falls, ID. The clinical studies were partially supported by a grant from the University of California-Davis Clinical and Translational Science Center (RR 024146).

Presented in abstract form at the 88th Annual Meeting of the Endocrine Society, June 24–28, 2006, Boston, Massachusetts.